Bond.az White LogoBond.az Black Logo

BofA Maintains Buy on MakeMyTrip, $60 Target

BofA Securities reiterates Buy on MakeMyTrip (MMYT) with $60 target due to margin expansion and cost control in Q4 results.

Jack Scott
ByJack Scott- Senior Editor
|
0

Bond.az reports that BofA Securities reiterated a Buy rating and $60 price target on MakeMyTrip (NASDAQ:MMYT), citing margin expansion and cost control in Q4 results.

The stock currently trades at $41.46. MakeMyTrip's Q4 revenue grew 8% year-over-year, in line with estimates. EBITDA came in 8% to 12% above expectations.

Margins expanded 120 bps sequentially to 16.6%. Marketing expenses as a percentage of gross bookings declined to 5.2%. Constant currency growth reached 10.7% for air, 11.5% for hotels, and 17.1% for bus.

Management noted that West Asia conflict and macro headwinds may impact Q1 growth. The company increases domestic travel offerings to shift customers from international travel.

BofA adjusted its fiscal 2027 and 2028 EPS estimates and maintained the $60 price target.

More News
Today / 08:32
|
341

Raymond James Upgrades SM Energy on Oil Strength

Raymond James upgrades SM Energy to Outperform with $55 target on oil strength. SM Energy benefits from Iran war oil price surge.

0
Today / 08:21
|
408

Jefferies Initiates SAB Biotherapeutics with Buy

Jefferies initiates coverage on SAB Biotherapeutics with a Buy rating and $11 target, focusing on SAB-142 diabetes therapy.

0
Today / 08:03
|
825

UBS Upgrades Packaging Corp. Stock Rating

UBS upgraded Packaging Corp. of America from Neutral to Buy, raising price target to $248. Learn more about PKG stock on Bond.az.

0
Today / 07:55
|
539

RBC Capital Cuts Home Depot Target on Housing Woes

RBC Capital cuts Home Depot price target to $340 on housing concerns and higher interest rate outlook. Stock trades near 52-week low.

0
Today / 07:54
|
619

Cantor Fitzgerald Initiates X-Energy with Overweight

Cantor Fitzgerald starts X-Energy with Overweight rating and $38 target, citing strategic position in advanced nuclear.

0
Today / 07:15
|
450

Jefferies downgrades Lanxess stock rating

Jefferies downgraded Lanxess to Underperform with a EUR16 target. Stock at $20.04. Weak chemicals market, Iran conflict impact, and demand risks ahead.

0
Yesterday / 20:01
|
493

Relay Therapeutics Stock Upgrade Boosts Price

Relay Therapeutics stock upgraded by Jones Trading to Buy with $20 target after positive zovegalisib trial data.

0
Yesterday / 19:51
|
929

SandRidge Energy Stock Rating Upgraded to Hold

Freedom Broker upgraded SandRidge Energy to Hold after strong Q1 2026 results. Dividend increased by 8.3% to $0.13 per share.

0
Yesterday / 19:30
|
676

Inuvo PT Cut to $2.50 After Weak Q1

Freedom Broker cut Inuvo's price target to $2.50 after weak Q1 results. Stock fell 20% as the company transitions to IntentKey AI platform. Analysts predict profitability this year.

0
Yesterday / 18:51
|
524

CoreWeave Stock Rises on AI Demand Outlook

Evercore ISI reaffirms Outperform for CoreWeave. AI demand drives positive outlook for the company.

0
Yesterday / 18:32
|
682

Jefferies Cuts Home Depot Price Target

Jefferies cuts Home Depot price target to $361 from $454, maintaining Buy rating. New target offers 20% upside from current price.

0
Yesterday / 15:23
|
845

Legence Price Target Raised on AI Data Center Demand

Tigress Financial raises Legence price target to $125 on AI data center demand, citing record backlog and growth acceleration.

0
...
BofA Maintains Buy on MakeMyTrip, $60 Target | Bond.az